CAS 1415119-52-6

C,C′-Dimethyl N,N′-[tricyclo[8.2.2.24,7]hexadeca-4,6,10,12,13,15-hexaene-5,11-diylbis[1H-benzimidazole-6,2-diyl[(2S,3aS,7aS)-octahydro-1H-indole-2,1-diyl][(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]bis[carbamate]

Description:

C,C′-Dimethyl N,N′-[tricyclo[8.2.2.24,7]hexadeca-4,6,10,12,13,15-hexaene-5,11-diylbis[1H-benzimidazole-6,2-diyl[(2S,3aS,7aS)-octahydro-1H-indole-2,1-diyl][(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]bis[carbamate] is a complex organic compound characterized by its intricate molecular structure, which includes multiple functional groups such as carbamates and benzimidazoles. This substance features a tricyclic framework, contributing to its unique three-dimensional shape and potential biological activity. The presence of multiple stereocenters indicates that it may exhibit chirality, which can influence its interactions in biological systems. The compound's extensive conjugated system, suggested by the hexaene component, may impart interesting electronic properties, potentially making it useful in applications such as organic electronics or photonics. Additionally, the presence of the octahydroindole moiety may enhance its solubility and reactivity. Overall, this compound's structural complexity and diverse functional groups suggest potential utility in medicinal chemistry or materials science, although specific applications would depend on further research and characterization.

Formula: C₆₀H₇₂N₈O₆

InChI: InChI=1S/C60H72N8O6/c1-33(2)53(65-59(71)73-5)57(69)67-49-13-9-7-11-41(49)31-51(67)55-61-45-25-23-39(29-47(45)63-55)43-27-35-15-19-37(43)21-17-36-16-20-38(22-18-35)44(28-36)40-24-26-46-48(30-40)64-56(62-46)52-32-42-12-8-10-14-50(42)68(52)58(70)54(34(3)4)66-60(72)74-6/h15-16,19-20,23-30,33-34,41-42,49-54H,7-14,17-18,21-22,31-32H2,1-6H3,(H,61,63)(H,62,64)(H,65,71)(H,66,72)/t41-,42-,49-,50-,51-,52-,53-,54-/m0/s1

InChI key: InChIKey=LSYBRGMTRKJATA-IVEWBXRVSA-N

SMILES: C([C@@H](NC(OC)=O)[C@H](C)C)(=O)N1[C@@H](C[C@]2([C@@]1(CCCC2)[H])[H])C=3NC=4C(N3)=CC=C(C4)C=5C=6CCC=7C=C(C(CCC(C5)=CC6)=CC7)C=8C=C9C(=CC8)N=C(N9)[C@H]%10N(C([C@@H](NC(OC)=O)[C@H](C)C)=O)[C@@]%11([C@](C%10)(CCCC%11)[H])[H]

Synonyms:

• C,C′-Dimethyl N,N′-[tricyclo[8.2.2.24,7]hexadeca-4,6,10,12,13,15-hexaene-5,11-diylbis[1H-benzimidazole-6,2-diyl[(2S,3aS,7aS)-octahydro-1H-indole-2,1-diyl][(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]bis[carbamate]
• ACH 3102
• Odalasvir
• Carbamic acid, N,N′-[tricyclo[8.2.2.24,7]hexadeca-4,6,10,12,13,15-hexaene-5,11-diylbis[1H-benzimidazole-6,2-diyl[(2S,3aS,7aS)-octahydro-1H-indole-2,1-diyl][(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]bis-, C,C′-dimethyl ester
• ACH 0143102

Odalasvir

CAS: 1415119-52-6

Odalasvir is a potent inhibitor of the HCV NS5A protein, which is essential for viral replication. It binds to the NS5A receptor and blocks the ion channel that is required for HCV entry into host cells. Odalasvir has been shown to inhibit the growth of HCV in cell culture and animal models.

Formula: C₆₀H₇₂N₈O₆

Purity: Min. 95%

Molecular weight: 1,001.3 g/mol

Ref: 3D-QGC11952

Odalasvir

CAS: 1415119-52-6

Odalasvir is a novel NS5A inhibitor for the treatment of hepatitis C.

Formula: C₆₀H₇₂N₈O₆

Color and Shape: Solid

Molecular weight: 1001.26

Ref: TM-T70731